Signaling Pathways - angiogenesis - GPR35 - CSF-1R - PARP
清除全部
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B4899 BLZ9451 CitationTarget: CSF-1RSummary: CSF-1R激酶抑制剂
- A8893 Rucaparib (free base)中文名: 瑞卡帕布Target: PARPSummary: PARP抑制剂
- B6367 NPPBTarget: Calcium-activated chloride channels (CaCC)|GPR35Summary: 氯离子通道抑制剂
- A8808 ME0328Target: PARPSummary: PARP抑制剂
- A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS激酶/CSF-1R抑制剂
- A3958 Veliparib dihydrochloride中文名: 维利帕尼二盐酸盐Target: PARPSummary: PARP-1/PARP-2抑制剂
- A3729 PJ34Target: PARPSummary: PARP-1抑制剂
- A3617 MK-4827中文名: 尼拉帕尼Target: PARPSummary: PARP-1/-2抑制剂
- A4211 Lenalidomide (CC-5013)中文名: 来那度胺Target: angiogenesisSummary: 抗肿瘤药物,抑制血管生成。